OpenEvidence
OpenEvidence, founded in 2021 in Cambridge, Massachusetts, provides a chatbot service for physicians.
Position in SVTR
Snapshot 2026-10-26- Startup SignalsTop 5%↓2
- Life Sciences#3of 249
- Healthcare Services#2of 86
- Search#1of 12
About
OpenEvidence, founded in 2021 in Cambridge, Massachusetts, provides a chatbot service for physicians. The New England Journal of Medicine has joined as a content partner, allowing clinicians using OpenEvidence to access content from NEJM Group journals.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Funding history
- 2026-09-16New funding round$250M
Investors · Andreessen Horowitz, Byers CapitalSource · forbes.com ↗
- 2026-01New funding round$250M
Investors · Kleiner Perkins, Mayo Clinic, GV, NVIDIA, Thrive Capital, DST, Craft VenturesSource · SVTR Weekly #141
- 2025-10-20Series C$200M
Investors · GV, Thrive Capital, BOND, Coatue, Sequoia Capital, Blackstone, Craft Ventures, Kleiner PerkinsSource · SVTR Weekly #128
- 2025-07-15Series B$210M
Investors · Conviction, GV, Thrive Capital, Kleiner Perkins, CoatueSource · SVTR Weekly #114
- 2025-02Series A$75M
Investors · Sequoia Capital (lead)Source · SVTR Weekly #093
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- OpenEvidence
AI medical evidence search and clinical decision support platform for clinicians
Undisclosed · $1.1B · 2026-09
$1.1B
United States
BusinessLatest roundTotal raisedDate- Commure
Platform providing healthcare organizations with AI workflows for administration, revenue cycle management, clinical documentation, coding, scheduling and operations
$750M · 2026-05
$750M - Health Data Analytics Institute
Uses predictive analytics and machine learning to help clinicians make better patient care decisions
Series C · $31M · 2023-10
$31M - ExaCare AI
AI automation tools for admissions and clinical decisions at post-acute care facilities
Series A · $30M · 2025-10
$30M
China
BusinessLatest roundTotal raisedDate- Purui Intelligence
AI-driven platform for end-to-end clinical trial automation and results delivery.
Series A · $14M · 2026-06
$14M - Shanghai Huayi Medical Technology Co., Ltd.
Shanghai Huayi Medical Technology, founded in 2015 and based in Shanghai, provides virtual standardized patient systems, TCM teaching simulation, virtual/physical hybrid training and skills-center exam management platforms to hundreds of medical schools and training institutions in China.
— - KURA Care Inc.
Digital lifestyle medicine after procedures for cardiovascular and other chronic diseases: Patient Engagement Layer (PEL) delivers AI personalized behavioral coaching and risk prediction to patients via SMS (no app); customers are risk-bearing providers and payers
—
Europe
BusinessLatest roundTotal raisedDate- Corti
Uses AI to assess patients in collaboration with clinicians
Series B · $60M · 2023-09
$60M - CiaoDott
Vertical AI voice platform for healthcare, supporting clinical communication and decision support for physicians and healthcare institutions
Pre-Seed · $2M · 2026-03
$2M - Saltroad
Clinician-led pediatric speech and language therapy platform matching UK families with registered speech therapists, using AI to cut therapist admin work.
Seed · 2026-06
—
Other / unspecified
BusinessLatest roundTotal raisedDate- Heidi Health
AI ambient documentation and clinical agent for clinicians (AI Care Partner)
Series C · $437M · 2026-09 · Valuation $900M
$437MValuation $900M - Kraionyx AI
High-reliability medical AI agents for physicians and healthcare organizations: clinical decision support, ambient voice-to-clinical-notes, physician case collaboration network
— - Reliant AI
Uses generative AI to help biopharma companies organize and analyze data for clinical trials or scientific publications
Seed · $11M · 2024-08
$11M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Related coverage
Investors that may fit
Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.